Trial Profile
Randomized, double blind, placebo control study to evaluate the safety and immunogenicity of CJ-50300 in healthy volunteers : phase I.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2020
Price :
$35
*
At a glance
- Drugs Smallpox vaccine (Primary)
- Indications Smallpox
- Focus Adverse reactions; Pharmacodynamics
- 12 Oct 2006 New trial record.